Author Archive: Special Contributor
A clinical trial being conducted at the University of Kentucky is investigating a new treatment strategy for Parkinson’s disease that, if successful, could drastically change future treatment and possibly halt or reverse brain degeneration. UK is the first in the U.S. to conduct the clinical trial.
Only four months ago, we marked the 50th anniversary of the 1963 March on Washington, that seminal moment when the eyes of the nation focused on 250,000 demonstrators in Washington, D.C., and where Dr. Martin Luther King, Jr., delivered his immortal “I Have a Dream” speech.
In another sign of the University of Kentucky’s emergence as one of the top universities in America, a new national ranking has UK among the top producers of U.S. Fulbright Scholars — one of the highest honors a faculty member can receive.
With the support of an innovative research model, a clinic devoted to individualized intervention approaches for children with autism spectrum disorder (ASD) has been making huge impacts in the lives of Central Kentucky children and their families.
“The first time we were wiped out, I was the only one left. We got a bunch of 17 and 18 year-old boys in from North and South Carolina. The next afternoon, we didn’t have one of them. They were ten years younger than I am and I was supposed to watch after them. It still hurts today, let me tell you.”
MATT JONES: Both Kentucky and Louisville have played their first exhibition games, and I think both teams showed some positive and some negatives. In Kentucky’s case, they came out sluggish against Transylvania and showed that they are going to be young. They are going to have some games when they are not totally into it. [...]